Main Street 1; Wall Street 0
Results 71 - 80 of 1609 : Previous 4 5 6 7 8 9 10 11 12 Next
Is GlaxoSmithKline Good Enough for You?
Keep your eye on margins.
The Only Way to Survive in This Drug Market
Gilead and J&J sign another pact.
The daily health-care news investors need to read.
Why Bristol-Myers Squibb's Earnings Are Outstanding
All cash flow is not created equal.
This Just In: Upgrades and Downgrades
A Swann song for Pfizer?
Is Merck Working Hard Enough for You?
Keep your eye on margins.
Is Vertex Pharmaceuticals' Growth for Real?
These two simple metrics can save you a lot of pain.
A Dividend Raise 7 Years in the Making
Merck investors get a long-awaited pay increase.
Here's How Bristol-Myers Squibb Is Making You So Much, So Fast
Don't just count the cash, time it.
A Sell-the-News Buying Opportunity
Ariad gets knocked down despite presenting good data.
Results 71 - 80 of 1609 : Previous 4 5 6 7 8 9 10 11 12 Next
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK